An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis

References

• Gralnek IM, Jensen DM, Kovacs TO, et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29: 44–50
   PubMed Web of Science ®Google Scholar
• Kovacs T, Jensen D. Therapeutic endoscopy for upper gastrointestinal bleeding. In: Taylor M, Gollan J, Peppercorn M, Steer M, Wolfe M, eds. Gastrointestinal Emergencies. Baltimore: Williams & Wilkins, 2006:181–98
   Google Scholar
• Laine L. Upper gastrointestinal tract hemorrhage. West J Med 1991;155:274–9
   PubMedGoogle Scholar
• Rubenstein JH, Eisen GM, Inadomi JM. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol 2004;99:1274–88
   Google Scholar
• Targownik LE, Spiegel BM, Dulai GS, et al. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol 2004;99:1306–15
   PubMed Web of Science ®Google Scholar
• McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001;49: 682–5
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD002907
   Google Scholar
• Nevens F. Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage. Aliment Pharmacol Ther 2004;20 (Suppl 3):18–22
   PubMedGoogle Scholar
• Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther 2003;18:253–62
   PubMed Web of Science ®Google Scholar
• Harry R, Wendon J. Management of variceal bleeding. Curr Opin Crit Care 2002;8:164–70
   PubMedGoogle Scholar
• Hui AJ, Sung JJ. Endoscopic treatment of upper gastrointestinal bleeding. Curr Treat Options Gastroenterol 2005;8:153–62
   PubMedGoogle Scholar
• Sorbi D, Gostout CJ, Peura D, et al. An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am J Gastroenterol 2003;98: 2424–34
   PubMed Web of Science ®Google Scholar
• D’Amico G, Pagliaro L, Bosch J. The treatment of portal hyper-tension: a meta-analytic review. Hepatology 1995;22:332–54
   Google Scholar
• Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;(1):CD002147. Published in Aliment Pharmacol Ther 2003;17: 53–64
   Google Scholar
• Yan BM, Lee SS. Emergency management of bleeding esophageal varices: drugs, bands or sleep? Can J Gastroenterol 2006;20:165–70
   PubMed Web of Science ®Google Scholar
• Gotzsche PC, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev 2005;(1):CD000193
   Google Scholar
• Zaman A. Current Management of Esophageal Varices. Curr Treat Options Gastroenterol 2003;6:499–507
   PubMedGoogle Scholar
• Ingrand P, Gournay J, Bernard P, et al. Management of digestive bleeding related to portal hypertension in cirrhotic patients: a French multicenter cross-sectional practice survey. World J Gastroenterol 2006;12:7810–14
   PubMed Web of Science ®Google Scholar
• British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 52. http://www.bnf. org/bnf [Last accessed 5 May 2006]
   Google Scholar
• Levacher S, Letoumelin P, Pateron D, et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–8
   PubMed Web of Science ®Google Scholar
• Curtis L, Netten A. Unit Costs of Health and Social Care 2005. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury 2005
   Google Scholar
• Department of Health. NHS reference costs 2005. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance [Last accessed 28 June 2006]
   Google Scholar
• Riley TR III, Bhatti AM. Preventive strategies in chronic liver disease: part II. Cirrhosis. Am Fam Physician 2001;64:1735–40
   PubMed Web of Science ®Google Scholar
• McCormick PA, Greenslade L, Matheson LA, et al. Vasoconstrictors in the management of bleeding from oesophageal varices. A clinico-economic appraisal in the UK. Scand J Gastroenterol 1995;30:377–83
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Boparai N, McCormick M, et al. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 2001;96:579–83
   PubMed Web of Science ®Google Scholar
• D’Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599–612
   Google Scholar
• Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653–9
   PubMed Web of Science ®Google Scholar
• Lay CS, Tsai YT, Teg CY, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997;25: 1346–50
   PubMed Web of Science ®Google Scholar
• HM Treasury. The Green Book: Appraisal and Evaluation in Central Government, Treasury Guidance. London: HM Treasury 2003
   Google Scholar
• Continuous Mortality Investigation Bureau. Mortality rates and complete expectations of life from the PFA92(C=2010) and PMA92(C=2010) tables of mortality. http://www.actuaries.org.uk [Last accessed 17 Jan 2006]
   Google Scholar
• Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329: 224–7
   PubMed Web of Science ®Google Scholar
• Combier E, Levacher S, Letoumelin P, et al. Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the pre-hospital management of acute gastro-intestinal haemorrhage in cirrhotic patients. Intensive Care Med 1999;25: 364–70
   PubMed Web of Science ®Google Scholar
• De Franchis R, ed. Portal Hypertension IV - Proceedings from the 4th Baveno International Consensus Workshop. Oxford: Blackwell Publishing 2006
   Google Scholar
• Gold MR, Siegel JE, Russell LB. Cost-effectiveness in health and medicine. New York: Oxford University Press 1996
   Google Scholar
• Fenwick E, O’Brien BJ, Briggs A. Cost-effectiveness acceptability curves – facts, fallacies and frequently asked questions. Health Econ 2004;13:405–15
   PubMed Web of Science ®Google Scholar
• D’Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003;124: 1277–91
   Google Scholar
• Gross M, Schiemann U, Muhlhofer A, Zoller WG. Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 2001;33:737–46
   PubMed Web of Science ®Google Scholar
• Triantos CK, Goulis J, Patch D, et al. An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy 2006;38:797–807
   PubMed Web of Science ®Google Scholar
• Rockey DC. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices. Curr Gastroenterol Rep 2006;8:7–13
   PubMedGoogle Scholar
• Kurstein P, Gluud LL, Willemann M, et al. Agreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews. J Hepatol 2005;43:984–9
   PubMed Web of Science ®Google Scholar
• Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;40:652–9
   PubMed Web of Science ®Google Scholar
• Ben-Ari Z, Cardin F, McCormick AP, et al. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 1999;31:443–50
   Google Scholar
• Solanki P, Chawla A, Garg R, et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003;18:152–6
   PubMed Web of Science ®Google Scholar